相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HLA-Dependent Hypersensitivity Reaction to Nevirapine in Chinese Han HIV-Infected Patients
Shicheng Gao et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
Incidence of Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome in an HIV Cohort An Observational, Retrospective Case Series Study
Nicole Mittmann et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2012)
HLA and pharmacogenetics of drug hypersensitivity
Rebecca Pavlos et al.
PHARMACOGENOMICS (2012)
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
David A. Ostrov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
HLA-DQ association and allele competition in Chinese narcolepsy
F. Han et al.
TISSUE ANTIGENS (2012)
Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent
Jing Yuan et al.
AIDS (2011)
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
Mark McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
HLA involvement in nevirapine-induced dermatological reaction in antiretroviral-treated HIV-1 patients
Shankarkumar Umapathy et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2011)
Quantifying the Metabolic Activation of Nevirapine in Patients by Integrated Applications of NMR and Mass Spectrometries
Abhishek Srivastava et al.
DRUG METABOLISM AND DISPOSITION (2010)
HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients
Soranun Chantarangsu et al.
PHARMACOGENETICS AND GENOMICS (2009)
HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients
Sirirat Likanonsakul et al.
AIDS Research and Therapy (2009)
HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz
Zulma G. Vitezica et al.
AIDS (2008)
Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug-induced liver injury
M. Garcia-Cortes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Discontinuation of Nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: The ATHENA cohort study
Ferdinand W. N. M. Wit et al.
CLINICAL INFECTIOUS DISEASES (2008)
HLA-B*5701 screening for hypersensitivity to abacavir
Simon Mallal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients
Elizabeth Phillips et al.
AIDS (2007)
Cytochrome P4502B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda
S. R. Penzak et al.
HIV MEDICINE (2007)
HLA-Cw8 primarily associated with hypersensitivity to nevirapine
Hiroyuki Gatanaga et al.
AIDS (2007)
HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients
Roberto Littera et al.
AIDS (2006)
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
SL Hung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts
AM Martin et al.
AIDS (2005)
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study
F van Leth et al.
LANCET (2004)
Hepatotoxicity following nevirapine-containing regimens in HIV-1-infected individuals
MMR De Maat et al.
PHARMACOLOGICAL RESEARCH (2002)
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
S Mallal et al.
LANCET (2002)
Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
JP Fagot et al.
AIDS (2001)
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver
T Lang et al.
PHARMACOGENETICS (2001)
分享论文
